Is HCA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HCA. It does not provide personalized investment advice.

HCA (HCA Healthcare, Inc.) Stock Analysis - Financials

HCA Healthcare, Inc. (HCA) is a publicly traded Healthcare sector company. As of October 27, 2026, HCA trades at $479.93 with a market cap of $101.55B and a P/E ratio of 22.61. HCA moved +3.15% today. Year to date, HCA is -1.09%; over the trailing twelve months it is +4.08%. Its 52-week range spans $310.18 to $556.52. Analyst consensus is buy with an average price target of $455.16. Rallies surfaces HCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are HCA's key financials?

HCA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HCA recently traded at $479.93. Market cap is $101.55B. P/E ratio is 22.61. Revenue is $64.97B.

HCA Key Metrics

Key financial metrics for HCA
Metric	Value
Price	$479.93
Market Cap	$101.55B
P/E Ratio	22.61
EPS	$19.25
Dividend Yield	0.78%
52-Week High	$556.52
52-Week Low	$310.18
Volume	22.37K
Avg Volume	0
Revenue (TTM)	$64.97B
Net Income	$6.09B
Gross Margin	0.00%

HCA Analyst Consensus

21 analysts cover HCA: 0 strong buy, 13 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $455.16.

Common questions about HCA

What are HCA's key financials?: HCA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HCA recently traded at $479.93. Market cap is $101.55B. P/E ratio is 22.61. Revenue is $64.97B.
Is HCA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HCA. It does not provide personalized investment advice.